Hormonal properties of norethisterone, 7α-methyl-norethisterone and their derivatives

Journal of Steroid Biochemistry and Molecular Biology

Volumn 74, Issue 4, 2000, Pages 213-222

  Schoonen, W G E J ^a   Deckers, G H ^a   De Gooijer, M E ^a   De Ries, R ^a   Kloosterboer, H J ^a  

^a NV ORGANON   (Netherlands)

Author keywords

7 Methyl norethisterone; Androgen receptor; Androgenic activity; Estrogen receptor; Estrogenic activity; Glucocorticoid receptor; Norethisterone; Progestagenic activity; Progesterone receptor; Steroid conversion

Indexed keywords

16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE; 3ALPHA HYDROXY 5ALPHA HYDROGEN 7ALPHA METHYL NORTHISTERONE; 3ALPHA HYDROXY 5ALPHA HYDROGEN NORTHISTERONE; 3ALPHA HYDROXY 7ALPHA METHYL NORTHISTERONE; 3BETA HYDROXY 5ALPA HYDROGEN 7 ALPHA METHYL NORTHISTERONE; 3BETA HYDROXY 5ALPHA HYDROGEN NORTHISTERONE; 3BETA HYDROXY 7ALPHA METHYL NORTHISTERONE; 3BETA HYDROXY NORETHISTERONE; 5ALPHA HYDROGEN 7ALPHA METHYL NORTHISTERONE; 5ALPHA HYDROXY NORTHISTERONE; 7ALPHA METHYL NORETHISTERONE; ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; NORETHISTERONE; NORETHISTERONE DERIVATIVE; PROGESTERONE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; HUMAN CELL; MALE; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; OVULATION INHIBITION; RABBIT; RAT; TRANSACTIVATION;

ADMINISTRATION, ORAL; ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CHO CELLS; CRICETINAE; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; NORETHINDRONE; ORCHIECTOMY; OVARIECTOMY; OVULATION; PROGESTERONE CONGENERS; RABBITS; RATS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PROGESTERONE; STRUCTURE-ACTIVITY RELATIONSHIP; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

ORYCTOLAGUS CUNICULUS;

EID: 0034668706     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(00)00125-4     Document Type: Article

References (27)

1. Clinical pharmacokinetics of oral contraceptive steroids
2. Recent pharmacokinetic studies of low-dose oral contraceptives
3. Characteristics of the new progestogens in combination oral contraceptives
4. Clinical pharmacokinetics of contraceptive steroids an update
5. Serum noretindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone
6. Endocrinological studies with (7α,17α)-17-hydroxy-7-methyl-19-nor-pregn-5(10)-en-20-yn-3-one (Org OD 14)
7. In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium
8. Intrinsic estrogenicity of some progestagenic drugs
9. A comparison of the potencies and activites of progestagens used in contraceptives
10. Comparative selectivity of contraceptive progestins in in vitro and in vivo pharmacologal tests
11. Different patterns of metabolism determine the relative anabolic activity of 19-norandrogens
12. The biological activity of 7α-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone
13. The metabolism of 19-nor contraceptive progestins modulates their biological activity at the neuroendocrine level
14. Comparative effects of short term treatment with norethisterone and sex steroids on gonadotropin secretion in rat pituitary cell cultures
15. Metabolic profiles of endogenous and ethynyl steroids in plasma and urine from women during administration of oral contraceptives
16. Simultaneous determination of norethisterone and six metabolites in human plasma by capillary gas chromatography with mass-selective detection
17. Norethisterone metabolites modulate the uteroglobulin and progesterone receptor gene expression in prepubertal rabbits
18. Metabolism of anabolic androgenic steroids
19. In vitro metabolism of 7α-methyl-19-nortestosterone by rat liver, prostate and epididymis
20. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines
21. Human progesterone receptor A and B isoforms in CHO cells. I Stable transfection of receptor and receptor-responsive reporter genes: Transcription modulation by (anti)progestagens
22. The assay of progestin
23. Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method
24. An ovarian hormone. Preliminary report on its location, extraction and partial purification and action in test animals
25. Identification and measurement by gas chromatography-mass spectrometry of norethindrone and metabolites in human urine and blood